Orexin a reverses propofoland thiopental induced cytoskeletal rearrangement in rat neurons

Journal of Physiology and Pharmacology

Volumn 65, Issue 4, 2014, Pages 531-541

  Turina, D ^a,b   Gerhardsson, H ^a,b   Bjornstrom, Karin ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Public Dental Service   (Sweden)

Author keywords

Actin; Anaesthesia; Cytoskeletal morphology; Ketamine; Orexin A; Vimentin

Indexed keywords

ACTIN; HYPNOTIC SEDATIVE AGENT; INTRAVENOUS ANESTHETIC AGENT; NEUROPEPTIDE; OREXINS; PROPOFOL; SIGNAL PEPTIDE; THIOPENTAL; TYROSINE; VIMENTIN;

ANIMAL; BRAIN; CELL CULTURE; CYTOSKELETON; DRUG EFFECTS; MALE; METABOLISM; NERVE CELL; NEWBORN; SPRAGUE DAWLEY RAT;

ACTINS; ANESTHETICS, INTRAVENOUS; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELLS, CULTURED; CYTOSKELETON; HYPNOTICS AND SEDATIVES; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEURONS; NEUROPEPTIDES; PROPOFOL; RATS, SPRAGUE-DAWLEY; THIOPENTAL; TYROSINE; VIMENTIN;

EID: 84906882999     PISSN: 08675910     EISSN: 18991505     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-585.
2. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998; 95: 322-327.
3. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998; 18: 9996-10015.
4. Hagan JJ, Leslie RA, Patel S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA 1999; 96: 10911-10916.
5. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999; 98: 437-451.
6. Sakurai T. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology. Regul Pept 2005; 126: 3-10.
7. Shirasaka T, Nakazato M, Matsukura S, Takasaki M, Kannan H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol 1999; 277: R1780-R1785.
8. Maleszka A, Smolinska N, Nitkiewicz A, et al. Expression of orexin A and B in the porcine hypothalamus during the oestrous cycle. J Physiol Pharmacol 2013; 64: 55-63.
9. Sakurai T. Roles of orexins and orexin receptors in central regulation of feeding behavior and energy homeostasis. CNS Neurol Disord Drug Targets 2006; 5: 313-325.
10. Szlachcic A, Majka J, Strzalka M, et al. Experimental healing of preexisting gastric ulcers induced by hormones controlling food intake ghrelin, orexin-A and nesfatin-1 is impaired under diabetic conditions. A key to understanding the diabetic gastropathy? J Physiol Pharmacol 2013; 64: 625-637.
11. Yasuda Y, Takeda A, Fukuda S, Suzuki H, Ishimoto M, Mori Y, et al. Orexin a elicits arousal electroencephalography without sympathetic cardiovascular activation in isofluraneanesthetized rats. Anesth Analg 2003; 97: 1663-1666.
12. Tose R, Kushikata T, Yoshida H, et al. Orexin A decreases ketamine-induced anesthesia time in the rat: the relevance to brain noradrenergic neuronal activity. Anesth Analg 2009; 108: 491-495.
13. Kushikata T, Hirota K, Yoshida H, et al. Orexinergic neurons and barbiturate anesthesia. Neuroscience 2003; 121: 855-863.
14. Bjornstrom K, Sjolander A, Schippert A, Eintrei C. A tyrosine kinase regulates propofol-induced modulation of the beta-subunit of the GABA(A) receptor and release of intracellular calcium in cortical rat neurones. Acta Physiol Scand 2002; 175: 227-235.
15. Bjornstrom K, Eintrei C. The difference between sleep and anaesthesia is in the intracellular signal: propofol and GABA use different subtypes of the GABA(A) receptor beta subunit and vary in their interaction with actin. Acta Anaesthesiol Scand 2003; 47: 157-164.
16. Bjornstrom K, Turina D, Loverock A, et al. Characterisation of the signal transduction cascade caused by propofol in rat neurons: from the GABA(A) receptor to the cytoskeleton. J Physiol Pharmacol 2008; 59: 617-632.
17. Turina D, Loitto VM, Bjornstrom K, Sundqvist T, Eintrei C. Propofol causes neurite retraction in neurones. Br J Anaesth 2008; 101: 374-379.
18. Turina D, Bjornstrom K, Sundqvist T, Eintrei C. Propofol alters vesicular transport in rat cortical neuronal cultures. J Physiol Pharmacol 2011; 62: 119-124.
19. Ivaska J, Pallari HM, Nevo J, Eriksson JE. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 2007; 313: 2050-2062.
20. Sihag RK, Inagaki M, Yamaguchi T, Shea TB, Pant HC. Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments. Exp Cell Res 2007; 313: 2098-2109.
21. Hansson ERL. Primary cultures of astroglia and neurons from different brain regions. In: A Dissection and Tissue Culture Manual of Nervous System. A. Shahar, A. Vernadakis, B. Haber (eds.). New York, Alan R. Liss, 1989, pp. 92-104.
22. 2+. J Biol Chem 1990; 265: 20976-20981.
23. Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS. Pharmacokinetics of propofol (diprivan) in elderly patients. Br J Anaesth 1988; 60: 146-150.
24. Smart D, Sabido-David C, Brough SJ, et al. SB-334867-A: the first selective orexin-1 receptor antagonist. Br J Pharmacol 2001; 132: 1179-1182.
25. Burch PG, Stanski DR. The role of metabolism and protein binding in thiopental anesthesia. Anesthesiology 1983; 58: 146-152.
26. Cordato DJ, Mather LE, Gross AS, Herkes GK. Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy. Anesthesiology 1999; 91: 1693-1702.
27. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
28. Shevchenko A, Chernushevic I, Wilm M, Mann M. "De novo" sequencing of peptides recovered from in-gel digested proteins by nanoelectrospray tandem mass spectrometry. Mol Biotechnol 2002; 20: 107-118.
29. Ihmsen H, Tzabazis A, Schywalsky M, Schwilden H. Propofol in rats: testing for nonlinear pharmacokinetics and modelling acute tolerance to EEG effects. Eur J Anaesthesiol 2002; 19: 177-88.
30. Jensen AG, Lindroth M, Sjolander A, Eintrei C. Propofol induces changes in the cytosolic free calcium concentration and the cytoskeletal organization of cultured human glial cells and primary embryonic rat brain cells. Anesthesiology 1994; 81: 1220-1229.
31. Shirasaka T, Yonaha T, Onizuka S, Tsuneyoshi I. Effects of orexin-A on propofol anesthesia in rats. J Anesth 2011; 25: 65-71.
32. Kelz MB, Sun Y, Chen J, et al. An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci USA 2008; 105: 1309-1314.
33. Kushikata T, Yoshida H, Kudo M, Kudo T, Hirota K. Changes in plasma orexin A during propofol-fentanyl anaesthesia in patients undergoing eye surgery. Br J Anaesth 2010; 104: 723-737.
34. Minami K, Uezono Y, Sakurai T, Horishita T, Shiraishi M, Ueta Y. Effects of anesthetics on the function of orexin-1 receptors expressed in Xenopus oocytes. Pharmacology 2007; 79: 236-242.
35. Orth JD, Krueger EW, Weller SG, McNiven MA. A novel endocytic mechanism of epidermal growth factor receptor sequestration and internalization. Cancer Res 2006; 66: 3603-3610.
36. Buccione R, Orth JD, McNiven MA. Foot and mouth: podosomes, invadopodia and circular dorsal ruffles. Nat Rev Mol Cell Biol 2004; 5: 647-657.
37. Peleg B, Disanza A, Scita G, Gov N. Propagating cellmembrane waves driven by curved activators of actin polymerization. PLoS One 2011; 6: e18635.
38. Krueger EW, Orth JD, Cao H, McNiven MA. A dynamincortactin- Arp2/3 complex mediates actin reorganization in growth factor-stimulated cells. Mol Biol Cell 2003; 14: 1085-1096.
39. Spiering D, Hodgson L. Dynamics of the Rho-family small GTPases in actin regulation and motility. Cell Adh Migr 2011; 5: 170-180.
40. von der Ohe CG, Darian-Smith C, Garner CC, Heller HC. Ubiquitous and temperature-dependent neural plasticity in hibernators. J Neurosci 2006; 26: 10590-10598.
41. Hemphill MA, Dabiri BE, Gabriele S, et al. A possible role for integrin signaling in diffuse axonal injury. PLoS One 2011; 6: e22899.
42. Meriane M, Mary S, Comunale F, Vignal E, Fort P, Gauthier- Rouviere C. Cdc42Hs and Rac1 GTPases induce the collapse of the vimentin intermediate filament network. J Biol Chem 2000; 275: 33046-33052.
43. Valgeirsdottir S, Claesson-Welsh L, Bongcam-Rudloff E, Hellman U, Westermark B, Heldin CH. PDGF induces reorganization of vimentin filaments. J Cell Sci 1998; 111: 1973-1980.
44. Nakamura Y, Hashimoto R, Amano M, et al. Localized phosphorylation of vimentin by rho-kinase in neuroblastoma N2a cells. Genes Cells 2000; 5: 823-837.
45. Hutchins JB, Casagrande VA. Vimentin: changes in distribution during brain development. Glia 1989; 2: 55-66.
46. Gad A, Lach S, Crimaldi L, Gimona M. Plectin deposition at podosome rings requires myosin contractility. Cell Motil Cytoskeleton 2008; 65: 614-625.
47. Bjornstrom K, Turina D, Strid T, Sundqvist T, Eintrei C. Orexin A inhibits propofol-induced neurite retraction by a phospholipase D/protein kinase Cepsilon-dependent mechanism in neurons. PLoS One 2014; 9: e97129.